Industry News
Simple Online Tool To Aid GPs In Early Ovarian Cancer Diagnosis
Jan 05, 2012
The lives of hundreds of women could be saved every year, thanks to a simple online calculator that could help GPs identify women most at risk of having ovarian cancer at a much earlier stage. Academics from The University of Nottingham and ClinRisk Ltd have developed a new QCancer algorithm using the UK QResearch database... Read More
News From The Journal Of Clinical Investigation: Jan. 3, 2012
Jan 05, 2012
ONCOLOGY: Cbx7 suppresses tumor growth The unregulated cell growth that occurs in cancer is in part related to changes in the expression of genes that control the cell cycle. CBX7 is a gene known to be involved in a repressor complex that is capable of altering the proteins around which DNA is wrapped such that genes cannot be expressed... Read More
Explaining Link Between Heart Failure And Diabetes
Jan 05, 2012
Either heart failure or diabetes alone is bad enough, but oftentimes the two conditions seem to go together. Now, researchers reporting in the January Cell Metabolism appear to have found the culprit that leads from heart failure to diabetes and perhaps a novel way to break that metabolic vicious cycle... Read More
New Test For Lung Cancer Screening Planned
Jan 04, 2012
Each year in the U.S., lung cancer kills more individuals than prostate, colon, and breast cancers combined. Often the disease goes undetected until it has reached an advanced and more difficult-to-treat stage. At present the only method to detect lung cancer are biopsies, which are highly involved and invasive for patients... Read More
Cellphone And Wireless Risks - Experts Criticize The Economist's Coverage
Jan 04, 2012
A critique, entitled "The Economist - and the Truth About Microwave Radiation Emitted from Wireless Technologies", of a report published in the The Economist (9/3/11), "Worrying about Wireless", has been published by experts in public health, neurosurgery, toxicology, oncology, electronic engineering, epidemiology, and cardiology from the USA, the UK, Sweden, Austria, Finland, ... Read More
During Ovulation, Females May Be More Susceptible To Infection
Jan 04, 2012
New research published in the Journal of Leukocyte Biology suggests that high levels of estradiol present prior to ovulation decreases immune system effectiveness resulting in growth and promotion of infection A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection... Read More
During Ovulation, Females May Be More Susceptible To Infection
Jan 04, 2012
New research published in the Journal of Leukocyte Biology suggests that high levels of estradiol present prior to ovulation decreases immune system effectiveness resulting in growth and promotion of infection A new research report in the Journal of Leukocyte Biology suggests that a woman's ovarian cycle plays an important role in her susceptibility to infection... Read More
Agent Shows Ability To Suppress Brain Metastasis And Related Damage
Jan 04, 2012
Scientists are one step closer to repairing the damage caused by brain metastasis, a major challenge in cancer treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research... Read More
Mayo Clinic Studies Identify Risk Factors In Rising Trend Of Liver Cancer
Jan 04, 2012
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S... Read More
Progression-Free Survival Of Patients With Advanced Ovarian Cancer Extended By Targeted Therapy
Jan 04, 2012
Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer... Read More
Previous Page Next Page